SCHEMBL17690376

SCHEMBL17690376

c1cc(-c2ccc(-c3cncnc3)cc2)c2c(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)cccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP1B1 Q16678 1/20 0.37
HDAC4 P56524 1/20 0.35
PDE6D O43924 1/20 0.35
DUSP3 P51452 1/20 0.35
PDK2 Q15119 1/20 0.33
TNF P01375 1/20 0.33
TSHR P16473 2/20 0.33
PDE10A Q9Y233 2/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CASP1 P29466 1/20 0.33
CYP2C19 P33261 1/20 0.33
CASP7 P55210 1/20 0.33
HBB P68871 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25972732 0.89 L3MBTL1 (0.50) ATML3MBTL1KDM4EHDAC4PDE6D
SCHEMBL25972769 0.89 L3MBTL1 (0.50) ATML3MBTL1KDM4EHDAC4PDE6D
SCHEMBL17690416 0.87 L3MBTL1 (0.52) ATML3MBTL1KDM4EHDAC4PDE6D
SCHEMBL17690374 0.87 CYP11B1 (0.43) ATML3MBTL1KDM4ETNFCYP1A2
SCHEMBL17690373 0.86 KDM4E (0.42) ATML3MBTL1KDM4EHDAC4PDE6D
SCHEMBL15446938 0.84 KDM4E (0.37) ATML3MBTL1KDM4ECYP1B1HDAC4
SCHEMBL12614073 0.83 ATM (0.41) ATML3MBTL1KDM4EHDAC4TSHR
SCHEMBL17655931 0.81 L3MBTL1 (0.46) ATML3MBTL1KDM4EHDAC4PDE6D
SCHEMBL25972795 0.81 L3MBTL1 (0.46) ATML3MBTL1KDM4EHDAC4PDE6D
SCHEMBL17693877 0.80 KDM4E (0.36) ATML3MBTL1KDM4ETNFMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892419-B2 Space-through charge transfer compound, and organic light emitting diode and display device using the same LG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20190081244-A1 Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same LG DISPLAY CO., LTD. (KR) 2019-03-14 US disclosed
EP-3010064-B1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO LTD (KR) 2017-07-19 EP disclosed
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-04-21 US disclosed
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-04-21 US disclosed
EP-3010064-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG Display Co., Ltd. (KR) 2016-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10892419-B2 Space-through charge transfer compound, and organic light emitting diode and display device using the same NLRP1, NLRP3, CYBA ATM 1902/4885L3MBTL1 1023/4885KDM4E 2885/4885
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME NLRP1, NLRP3, CYBA ATM 1902/4885L3MBTL1 1023/4885KDM4E 2885/4885
US-20190081244-A1 Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same NLRP1, NLRP3, CYBA ATM 1902/4885L3MBTL1 1023/4885KDM4E 2885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.